SCHEMBL3527784

SCHEMBL3527784

Cc1ccccc1-c1cc(NC(=O)C(C)C)cc2c1CCN(C(=O)c1ccccc1)C2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 2/20 0.44
CCND1 P24385 2/20 0.44
ALDH1A1 P00352 4/20 0.43
PLA2G7 Q13093 2/20 0.42
NAMPT P43490 4/20 0.40
TSHR P16473 1/20 0.39
PTGS1 P23219 1/20 0.39
RAB9A P51151 3/20 0.39
NPC1 O15118 2/20 0.39
PTGDR2 Q9Y5Y4 1/20 0.39
NPSR1 Q6W5P4 2/20 0.39
HPGD P15428 2/20 0.39
HTT P42858 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
LMNA P02545 1/20 0.39
RECQL P46063 1/20 0.39
KEAP1 Q14145 1/20 0.39
NFE2L2 Q16236 1/20 0.39
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3528315 0.90 NOTUM (0.43) CDK4CCND1ALDH1A1NAMPTRAB9A
SCHEMBL3524858 0.85 PDK2 (0.42) NAMPTRAB9ANPC1SMN1; SMN2
SCHEMBL169287 0.79 NOTUM (0.42) ALDH1A1NAMPTRAB9ANPC1HTT
SCHEMBL3533607 0.75 KMT2A (0.42) ALDH1A1RAB9ANPC1NPSR1HPGD
SCHEMBL16104413 0.75 RAB9A (0.42) ALDH1A1RAB9ANPC1SMN1; SMN2LMNA
SCHEMBL20439976 0.71 POLB (0.50) CDK4CCND1ALDH1A1PTGS1PTGDR2
SCHEMBL10211721 0.71 HPGD (0.56) ALDH1A1NAMPTPTGDR2NPSR1HPGD
SCHEMBL20425836 0.69 HPGD (0.48) ALDH1A1PTGS1RAB9APTGDR2HPGD
SCHEMBL20439762 0.68 PTGS1 (0.46) CDK4CCND1ALDH1A1NAMPTPTGS1
SCHEMBL14591322 0.67 PTGDR2 (0.58) ALDH1A1NAMPTPTGDR2NPSR1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120101115-A1 Compounds For Inducing Cellular Apoptosis QUEEN MARY AND WESTFIELD COLLEGE (GB) 2012-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120101115-A1 Compounds For Inducing Cellular Apoptosis BAD, BAX, CASP3 CDK4 53/4885CCND1 320/4885ALDH1A1 2122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.